Compounds > umifenovir
Page last updated: 2024-09-03

umifenovir and bms-790052

umifenovir has been researched along with bms-790052 in 2 studies

Compound Research Comparison

Studies
(umifenovir)		Trials
(umifenovir)		Recent Studies (post-2010)
(umifenovir)		Studies
(bms-790052)		Trials
(bms-790052)		Recent Studies (post-2010) (bms-790052)
23423172759120722

Protein Interaction Comparison

ProteinTaxonomyumifenovir (IC50)bms-790052 (IC50)
Cytochrome P450 3A4Homo sapiens (human)7.2

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Chao, CM; Hsueh, PR; Lai, CC1

Reviews

1 review(s) available for umifenovir and bms-790052

ArticleYear
Clinical efficacy of antiviral agents against coronavirus disease 2019: A systematic review of randomized controlled trials.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2021, Volume: 54, Issue:5

    Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Carbamates; Cobicistat; COVID-19 Drug Treatment; Darunavir; Dibenzothiepins; Drug Combinations; Drug Therapy, Combination; Humans; Imidazoles; Indoles; Iran; Lopinavir; Morpholines; Pyrazines; Pyridones; Pyrrolidines; Randomized Controlled Trials as Topic; Ritonavir; SARS-CoV-2; Sofosbuvir; Treatment Outcome; Triazines; Valine

2021

Other Studies

1 other study(ies) available for umifenovir and bms-790052

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023